3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
CNS
2
Breast
2
Head & Neck
1
Gynecologic
1
Genitourinary
1
Conditions
Prostatic Neoplasms
1635
Carcinoma, Renal Cell
504
Urinary Bladder Neoplasms
462
Carcinoma, Transitional Cell
234
Breast Neoplasms
228
Kidney Neoplasms
215
Neoplasms
193
Carcinoma, Non-Small-Cell Lung
173
Colorectal Neoplasms
171
Ovarian Neoplasms
164
Melanoma
163
Neoplasm Metastasis
144
Lung Neoplasms
129
Non-Muscle Invasive Bladder Neoplasms
105
Pancreatic Neoplasms
103
Stomach Neoplasms
101
Uterine Cervical Neoplasms
92
Squamous Cell Carcinoma of Head and Neck
85
Endometrial Neoplasms
84
Carcinoma, Hepatocellular
77
Sarcoma
75
Esophageal Neoplasms
72
Head and Neck Neoplasms
70
Triple Negative Breast Neoplasms
67
Adenocarcinoma
66
Colonic Neoplasms
53
Testicular Neoplasms
52
Disease
47
Urologic Neoplasms
46
Wilms Tumor
44
Interventions
Androgen Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Recurrence, Local
×
Genitourinary
×
1 year
×
Clear all
NCT07483658
2026-03-19
HYP-OP-RT
CHU de Quebec-Universite Laval
Phase NA
Not yet recruiting
434 enrolled